Luxembourg - Re-Export of Penicillins or Streptomycins Not in Dosage Forms

Since 2014, Luxembourg Re-Export of Penicillins or Streptomycins Not in Dosage Forms was down by 18.6% year on year. At $427.39 in 2019, the country was ranked number 9 among other countries in Re-Export of Penicillins or Streptomycins Not in Dosage Forms. Luxembourg is overtaken by Uganda, which was number 8 with $4,987 and is followed by Barbados at $123. New Zealand ranked the highest with $476,039.52 in 2019, that is a fall of 2.3% versus 2018. United States, Saudi Arabia and United Arab Emirates respectively ranked number 2, 3 and 4 in this ranking. Guyana recorded the best 5 years average growth at +152% per year, while United States recorded the worst performance at -25.7% per year.

Loading...

Date US Dollars
2019 427.39
2018 608.72
2017 40.58
2016 14.00
2015
Download all data from 2010 to 2019

How does Luxembourg rank in Re-Export of Penicillins or Streptomycins Not in Dosage Forms?

# 11 Countries US Dollars Last YoY 5‑years CAGR
1 #1
New Zealand
476,039.52 2019 -2.3 % -7.7 % View data
2 #2
United States
108,118.00 2019 -33.5 % -25.7 % View data
8 #8
Uganda
4,987.00 2016 NA NA View data
9 #9
Luxembourg
427.39 2019 -29.8 % -18.6 % View data
10 #10
Barbados
123.00 2018 +402.0 % NA View data
Compare all 11 countries

Go Top